• VENOIMUN liquid 50 ml bottle

VENOIMUN liquid 50 ml bottle

Description for VENOIMUN liquid 50 ml bottle:

Immunobiological properties.
Due to the presence of antibodies against different pathogens - bacteria and viruses (hepatitis A and B, herpes, chicken pox, influenza, measles, mumps, polio, rubella, pertussis, Staphylococcus aureus, Escherichia coli, pneumococci and other infections).
The high efficiency is achieved by rapid intravenous immunoglobulin 100% entering the bloodstream antibodies.
The drug also has non-specific activity, which manifests itself in increasing resistance.

Indications for use.
The drug used to treat:
- Primary antibody deficiency syndrome - agammaglobulinemia or hypogammaglobulinemia (congenital form, the period of physiological deficits in newborns);
- Secondary antibody deficiency syndrome - blood diseases, iatrogenic immunodeficiency, as a result of immunosuppressive therapy, acquired immunodeficiency syndrome (AIDS), especially in children infected with human immunodeficiency virus;
- Severe bacterial and viral infections and toxic, surgical complications, accompanied by bacteremia and septikopiemicheskimi states, the preparation of surgical patients for surgery;
- Cytopenia of various origins (acute and chronic leukemia, aplastic anemia, a condition after treatment with cytostatics);
- Autoimmune diseases (idiopathic thrombocytopenic purpura, etc.);
- Prevent and treat infections in premature infants with low birth weight (1500 g). The introduction of the drug to pregnant women with threatened preterm delivery reduces infant mortality and risk of infection.

Dosage and administration.
Immunoglobulin for intravenous use only in a hospital, subject to all rules of asepsis.
Before the introduction of the drug is maintained at a temperature (20 +2) ° C for at least two hours. Opaque solutions and solutions with the use of sludge is not to be.
Adult single dose is 4-8 ml (0.2-0.4 g) per 1 kg of body weight, was well tolerated and does not cause adverse reactions.
When gistotsitostaticheskoy myelosuppression in order to prevent infectious complications common - 4 ml (0.2 g) per 1 kg body weight for 4-5 days.
When gaptenovom agranulocytosis 8.5 ml (0.42 g) per 1 kg body weight for 4 days.
When gipoimmunoglobulenemii, observed in chronic lympho-and myeloproliferative disorders, as well as immune thrombocytopenia and gaptenovoy - 4-8 ml (0.2-0.4 g) per 1 kg body weight for 4-5 days.
For children one-time dose of 3-4 ml (0.15-0.2 g) for 1 kg of body weight. On selected single dose may be increased to 8 ml (0.4 g) per 1 kg body weight, but not more than 10 ml (0.5 g) per 1 kg of body weight.
Primary and secondary immunodeficiency - 4 ml (0.2 g) for 1 kg of body weight one-time or more at intervals of 3-4 weeks.
In severe bacterial and viral infections - 4-8 ml (0.2-0.4 g) per 1 kg of body weight. The number of transfusion depends on the severity of the process.
If cytopenia of various origins - 4 ml (0.2 g) per 1 kg of body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days.
In autoimmune diseases - 4-8 ml (0.2-0.4 g) per 1 kg of body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days. Heading dose should not exceed 2 g per 1 kg body weight.
Immunoglobulin immediately before injection diluted with sterile 0.9% sodium chloride solution or 5% sterile glucose solution at the rate of 1 volume of the drug in 4 volumes of solution for reconstitution.
Divorced immunoglobulin administered intravenous drip at a rate 5-10 drops per minute. The course of treatment consists of 1-2 or 5 transfusions, which are carried out daily. According to testimony, treatment can be repeated after 3-4 weeks.

Side effects.
Typically, the reaction to the introduction of an immunoglobulin is absent. But for some individuals with altered reactivity may develop allergic reactions of various types, in some cases - anaphylactoid reactions in connection with which the person receiving the drug should be under medical supervision.

The drug is not administered to persons with a history of allergic reactions to proteins in human blood.
Persons suffering from allergic or prone to allergic reactions, a drug made against the background of antihistamines. It is recommended to continue taking antihistamines for eight days after treatment.
In the period of acute allergic process is performed after injection of the drug permits an allergist.
Persons suffering from diseases in the genesis of which are the leading immunopathological mechanisms (connective tissue disease, immune blood disease, nephritis), the drug is prescribed after consulting an appropriate expert.

Features of the drug.
For drug administration must use a separate system.
Transfusion therapy with immunoglobulin for intravenous administration can be performed in combination with other drugs.

Release form.
Normal human immunoglobulin for intravenous use are produced in bottles of 25 ml (1 dose) and 50 ml (2 doses).

Storage and transportation.
Drug store in a dark, dry place at temperatures from 2 to 10 ° C.
The drug does not freeze!
Transportation is carried out at temperatures from 2 to 10 ° C.
Shelf life - 1 year.

VENOIMUN liquid 50 ml bottle

  • Product Code: 90
  • Availability: In Stock
  • $215.00

  • Ex Tax: $215.00

Tags: VENOIMUN liquid 50 ml bottle